These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15604273)

  • 21. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.
    Murphy AN; Unsworth EJ; Stetler-Stevenson WG
    J Cell Physiol; 1993 Nov; 157(2):351-8. PubMed ID: 7693724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.
    Mummidi S; Das NA; Carpenter AJ; Yoshida T; Yariswamy M; Mostany R; Izadpanah R; Higashi Y; Sukhanov S; Noda M; Siebenlist U; Rector RS; Chandrasekar B
    J Cell Physiol; 2019 Dec; 234(12):22242-22259. PubMed ID: 31074012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatitis-associated protein inhibits human pancreatic stellate cell MMP-1 and -2, TIMP-1 and -2 secretion and RECK expression.
    Li L; Bachem MG; Zhou S; Sun Z; Chen J; Siech M; Bimmler D; Graf R
    Pancreatology; 2009; 9(1-2):99-110. PubMed ID: 19077460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.
    Lamoreaux WJ; Fitzgerald ME; Reiner A; Hasty KA; Charles ST
    Microvasc Res; 1998 Jan; 55(1):29-42. PubMed ID: 9473407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal.
    Pérez-Martínez L; Jaworski DM
    J Neurosci; 2005 May; 25(20):4917-29. PubMed ID: 15901773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study.
    Aricò A; Giantin M; Gelain ME; Riondato F; Comazzi S; Rütgen BC; Essler SE; Dacasto M; Castagnaro M; Aresu L
    BMC Vet Res; 2013 May; 9():94. PubMed ID: 23641796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
    Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
    Wang H; Keiser JA
    Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
    Sandri S; Faião-Flores F; Tiago M; Pennacchi PC; Massaro RR; Alves-Fernandes DK; Berardinelli GN; Evangelista AF; de Lima Vazquez V; Reis RM; Maria-Engler SS
    Pharmacol Res; 2016 Sep; 111():523-533. PubMed ID: 27436149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).
    Yoshida D; Nomura R; Teramoto A
    J Neurooncol; 2008 Sep; 89(2):141-50. PubMed ID: 18493720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
    Pufe T; Harde V; Petersen W; Goldring MB; Tillmann B; Mentlein R
    J Pathol; 2004 Mar; 202(3):367-74. PubMed ID: 14991903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression.
    Higashi Y; Mummidi S; Sukhanov S; Yoshida T; Noda M; Delafontaine P; Chandrasekar B
    Cell Signal; 2019 May; 57():10-20. PubMed ID: 30716386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells.
    Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
    Toxicol Lett; 2011 Feb; 201(1):62-71. PubMed ID: 21167264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.
    Fernández CA; Butterfield C; Jackson G; Moses MA
    J Biol Chem; 2003 Oct; 278(42):40989-95. PubMed ID: 12900406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2.
    Merchant SJ; Narumiya H; Zhang Y; Guilbert LJ; Davidge ST
    Hypertens Pregnancy; 2004; 23(1):47-60. PubMed ID: 15117600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells.
    Djafarzadeh R; Sauter M; Notohamiprodjo S; Noessner E; Goyal P; Siess W; Wörnle M; Ribeiro A; Himmelein S; Sitter T; Nelson PJ
    PLoS One; 2012; 7(4):e33963. PubMed ID: 22558080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo.
    Seo DW; Saxinger WC; Guedez L; Cantelmo AR; Albini A; Stetler-Stevenson WG
    Peptides; 2011 Sep; 32(9):1840-8. PubMed ID: 21871510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.